Indaptus Therapeutics, INC. (INDP) SEC Filings — 2025

Filings

• Indaptus Therapeutics Reports Key Corporate Events — 8-K · Dec 23, 2025
• Indaptus Therapeutics Faces Going Concern Doubt Amid Rising R&D Costs — 10-Q · Nov 12, 2025
• Indaptus Therapeutics Files 8-K — 8-K · Sep 4, 2025
• Indaptus Amends S-1, Reveals Recent Capital Raises Totaling Millions — S-1/A · Sep 3, 2025
• Indaptus Launches Best-Efforts Offering of Stock, Warrants — S-1 · Sep 2, 2025
• Indaptus Therapeutics Files 8-K on Financials — 8-K · Aug 13, 2025
• Indaptus Therapeutics Files 8-K on Equity Sales & Shareholder Votes — 8-K · Jul 29, 2025
• Indaptus Therapeutics Files 8-K Under 'Other Events' — 8-K · Jul 16, 2025
• Indaptus Therapeutics Files 8-K with Financial Obligations — 8-K · Jul 1, 2025
• Indaptus Therapeutics Files 8-K on Security Holder Rights — 8-K · Jun 26, 2025
• Indaptus Seeks Shareholder Nod for Private Placement to Meet Nasdaq Rules — DEF 14A · Jun 23, 2025
• Indaptus Therapeutics Files 8-K: New Obligations & Equity Sales — 8-K · Jun 13, 2025
• Indaptus Therapeutics Files 8-K — 8-K · Jun 11, 2025
• Indaptus Therapeutics Files Q1 2025 10-Q — 10-Q · May 14, 2025
• Indaptus Therapeutics Executive Compensation Details — DEF 14A · Apr 28, 2025
• Indaptus Therapeutics Files 8-K on Financials — 8-K · Mar 13, 2025
• Indaptus Therapeutics Files 8-K on Agreements — 8-K · Feb 12, 2025
• Indaptus Therapeutics Fails Nasdaq Listing Standards — 8-K · Jan 31, 2025
• Indaptus Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Jan 14, 2025